Pulmonary Vascular Disease AND COR Pulmonale — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Pulmonary Vascular Disease AND COR Pulmonale.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Pulmonary Vascular Disease AND COR Pulmonale and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Jimenez D, Bikdeli B, Tapson V, Becattini C, et al. Systematic review of prognostic scores and individual predictor variables for short-term mortality after acute pulmonary embolism Pulmonology, 2026.PMID 42461710
[2]Alfonso DM, Sy JC, Palabrica MC The Apelin-APJ Axis in Heart Failure: Mechanistic Insights, Clinical Evidence, and Translational Challenges Cardiovasc Drugs Ther, 2026.PMID 42455245
[3]Almaimani M, Alamri SA Finerenone Beyond Diabetic Kidney Disease: Emerging Evidence and Potential Systemic Implications J Clin Med, 2026.PMID 42452314
[4]Larsen TB, Flyckt RNH, Henriksen MB, Brasen CL, et al. Cardiovascular risk after cancer in patients with ischemic heart disease or peripheral artery disease Cardiooncology, 2026.PMID 42387666
[5]Cabré F, Cascante M Present and Future Options for Pharmacotherapy in Cardiovascular Disease: Hemodynamic and Mechanistic Therapeutic Targets Med Sci (Basel), 2026.PMID 42346870
[6]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[7]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005
[8]Osborne AK, Brown RD, Sillence E Effects of Social Media Narratives on Affective and Behavioral Responses to Menopause Content: Randomized Online Experimental Study JMIR Form Res, 2026.PMID 42467962

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Pulmonary Vascular Disease AND COR Pulmonale and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Jimenez D, Bikdeli B, Tapson V, Becattini C, et al. Systematic review of prognostic scores and individual predictor variables for short-term mortality after acute pulmonary embolism Pulmonology, 2026.PMID 42461710
[2]Alfonso DM, Sy JC, Palabrica MC The Apelin-APJ Axis in Heart Failure: Mechanistic Insights, Clinical Evidence, and Translational Challenges Cardiovasc Drugs Ther, 2026.PMID 42455245
[3]Almaimani M, Alamri SA Finerenone Beyond Diabetic Kidney Disease: Emerging Evidence and Potential Systemic Implications J Clin Med, 2026.PMID 42452314
[4]Larsen TB, Flyckt RNH, Henriksen MB, Brasen CL, et al. Cardiovascular risk after cancer in patients with ischemic heart disease or peripheral artery disease Cardiooncology, 2026.PMID 42387666
[5]Cabré F, Cascante M Present and Future Options for Pharmacotherapy in Cardiovascular Disease: Hemodynamic and Mechanistic Therapeutic Targets Med Sci (Basel), 2026.PMID 42346870
[6]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[7]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005
[8]Osborne AK, Brown RD, Sillence E Effects of Social Media Narratives on Affective and Behavioral Responses to Menopause Content: Randomized Online Experimental Study JMIR Form Res, 2026.PMID 42467962